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Introduction
The objective of ischemic stroke (IS) treatment is to achieve revascularization in cerebral arteries to restore blood flow and improve perfusion in the ischemic region of the brain. Although more information about cerebral arterial blood flow could be helpful for treatment planning, additional procedures required for arterial flow measurement for IS patients may consume the treatment window and increase risks for complications. Image-based computational analysis has been used in cerebral vascular research. [1] [2] [3] [4] However, to the best of our knowledge there is no available arterial flow analysis that can use standard clinical IS computed tomography angiography (CTA) imaging protocols and simulate the blood flow within the entire Circle of Willis to estimate the arterial flow distribution.
Information about cerebral arterial flow velocity in occluded vessels may be helpful for the evaluation of how effectively fibrinolytic agents will be able to contact and disrupt a lesion. In cases with clear retrograde filling from the collaterals, the pressure difference between the proximal end and distal end of a thrombosis may be useful to assess the magnitude of flow changes after recanalization to evaluate the effectiveness of endovascular therapy. Unlike cerebral aneurysm flow studies, which usually focus on a single inflow artery for the flow analysis, the importance of collateral flow in IS also stresses that the analysis of IS requires taking the entire Circle of Willis vascular structure into account.
Because occlusions commonly occur in the Circle of Willis, tools that can be integrated into existing stroke Division of Interventional Neuroradiology, David Geffen School of Medicine at UCLA, USA treatment protocol to obtain IS blood flow information in the Circle of Willis without additional procedures are useful both for improving understanding of IS and its treatment. Because of the IS CTA protocol, there are also limitations that hinder recording simultaneous arterial flow data to allow comparisons of blood flow velocity in different branches. While there are existing approaches for measurement of cerebral hemodynamics in IS patients such as perfusion analysis, there are no practical methods to obtain detailed arterial flow data for various regions of the Circle of Willis.
We have developed the patient-specific three-dimensional (3D) Stroke Arterial Flow Estimation (SAFE) method. It uses a computer flow simulation to provide detailed time-resolved flow information in the Circle of Willis without additional procedures. In this paper, we show the utilization of SAFE analysis. IS patients' 3D CTA images are used to automatically reconstruct patient-specific Circle of Willis and then combined with multi-vessel flow simulation to obtain flow data for the cerebral arteries. As imaging is a key step for stroke management and 3D CTA is commonly integrated into the workflow to evaluate the collateral vessel anatomy, the proposed flow simulation can function as a post-processing analysis and not affect the existing workflow and provide arterial flow analysis in acute cases. This additional information about arterial flow may help in the study of different IS treatments and facilitate new device design.
Methods

3D reconstruction of cerebral vascular structure
Although CTA images are sufficient for vascular morphology evaluations, the image quality is insufficient to rebuild mathematical models using standard thresholding methods for computational fluid dynamics (CFD) simulation that were previously developed to use high-resolution 3D digital subtraction angiography (DSA) images. We have overcome this technical problem based on a newly developed geodesic 3D vascular reconstruction method.
5 3D CTA images for clinical evaluation of vascular anatomy were used. The scan protocol was standardized with 3 cc per second of iohexol (Ominipaque 350; GE Healthcare, Milwaukee, WI), 1 mm slice collimation, 512 Â 512 matrix size and 0.5 mm reconstruction interval. CTA digital imaging and communications in medicine (DICOM) images were transferred to an HP Z820 workstation. Geodesic 3D vascular structure reconstruction with adaptive parameter algorithms was implemented for vessel segmentations. 5 It used iterative methods based on parameters of vessel shapes to extract the vascular structure. Because the complex vessel network has different bifurcation angles and caliber changes, this iterative method repetitively corrected the segmentation results using image gradients as references. After the vessel segmentation, level-set based volumetric analysis and finite element methods were then applied to create the patient-specific mathematical model for blood flow simulations. 6 
Computation of cerebral blood flow (CBF)
Based on the realistic vascular structure, we implemented the Circle of Willis as a flow network. In the SAFE analysis, the right and left internal carotid arteries and basilar artery were proscribed as the inflow vessels supplying the circle of Willis. Based on the hemodynamic simulation, SAFE computed the flow velocity, pressure and flow distributions in various regions of cerebral arteries. Specifically, the pulsatile flow formulation was applied and blood flow was modeled as an incompressible Newtonian fluid using the unsteady 3D Navier-Stokes equations. 7, 8 Numerical solutions of the Navier-Stokes equations were obtained using a fully implicit finite-element formulation with pulsatile flow functions. 7 The entire analysis took approximately four hours on an HP Z820 workstation (Dual Xeon E5-2665). Figure 1 shows the process of SAFE analysis from reconstruction of a vascular model for the Circle of Willis to the flow analysis results. The flow data including the distribution of the 
Technique verification with CTP data
This research was approved by the institutional review board. To verify blood flow data obtained from SAFE simulation, the regional cerebral blood flow (CBF) in the arteries obtained from SAFE and CBF obtained from CT perfusion (CTP) were compared. The CTP data were acquired on the same day from the same patients as the 3D CTA. Because CTP data represents the blood flow perfusion in different brain territories, the corresponding arterial CBF was expected to be in the same range as the CTP CBF data. Based on the standard CTP protocol, a clinical CT scanner (Sensation 64 system, SIEMES, Germany) was used and a 4 mm section through the area of infarct was acquired for a total of 45 seconds at 80 kVp and 190 mA. The image matrix was 512 Â 512 with pixel spacing 0.45 mm Â 0.45 mm.
Iodinate contrast medium (Omnipaque 350, GE Healthcare, Milwaukee, WI) was injected intravenously. Data of CBF for right and left anterior cerebral artery (ACA), middle cerebral artery (MCA), and posterior cerebral artery (PCA) territories were recorded and compared with the arterial CBF computed by SAFE in the corresponding ACA, MCA, and PCA.
Results
A pilot study analyzing the CBF in four IS patients is shown in Figure 2 . SAFE analysis based on the CTA images was compared with CTP data acquired from the same patient during the same CT scanning session. Case 1 was a 50-year-old male patient. His CTA images showed an abrupt cut-off of the proximal left M1 segment and CTP showed ischemia throughout the left MCA territory. Case 2 was a 53-year-old female patient who had significant thrombus at the right M1 segment. The CTP showed complete infarction of the right prefrontal MCA territory. Case 3 was an 87-yearold male patient whose CTA images showed no focal stenosis in the Circle of Willis nor its proximal main branch vessels; however, CTP images showed decreased perfusion in the right MCA territory. Case 4 was a 42-year-old male patient. CTA images showed occlusion of the proximal left M1 and narrowing of left A1. CTP showed moderate cerebral ischemia in the left MCA territory. The left column of Figure 2 presents the arterial flow rate in the Circle of Willis resulting from SAFE and the right column presents the CTP tissue volumetric flow rate. Based on SAFE analysis, the normal range of blood flow rate in the Circle of Willis is 40-70 cm/sec (green), high flow is >100 cm/sec (red), and slow flow <20 cm/sec (dark blue).
SAFE analysis showed that in Case 1 the blood flow from the posterior circulation was supplying the left distal MCA through the left posterior communicating arteries. High flow rate was observed only in the distal M1. Because of the collateral flow and pressure, the flow rate in the left PCA was decreased. The occlusion also resulted in an altered pressure gradient in the right ACA and higher flow rate in the left ACA. Case 2, which had a thrombus at right M1 had slow and turbulent flow at the right ICA, with very minimal flow passing from the right ICA through the right ACA. Because of the collateral flow and pressure gradient change, a high rate of blood flow in the left ACA was observed. This high flow supplies both left and right A2 segments. Case 3, which had no stenosis in the Circle of Willis, had slow flow in the right ICA, MCA, and ACA. A higher flow rate in the left ACA was observed; however, the passing of left ACA flow to right A2 is minimal because of the pressure gradient. Case 4, which had occlusion at left M1, had no arterial flow passing the left MCA and high flow in the narrowed left A1. We also found turbulent flow in the right MCA and ACA, and slow right PCA flow resulted from the pressure increase in the right ICA.
Quantitative data of CBF in cerebral arteries computed with SAFE and CBF in perfusion territories computed through CTP in all cases were also collected, and are presented in Table 1 . Regression analysis was performed with IBM SPSS Statistics 22 to compare local volumetric flow data in from SAFE (arterial flow) and CTP (CBF, flow in perfusion territories). The flow data obtained from SAFE and CTP were found to be significantly correlated, with ¼ 0.73, 95% confidence interval (CI) (0.4, 1.1), r ¼ 0.72, p ¼ 0.000158 (Figure 3) . These results support that SAFE analysis provides reliable arterial flow information that can be complementary to perfusion data.
Discussion
Currently there is a major void in understanding the mechanism of IS-related cerebral arterial flow changes affecting the entire cerebral circulation. The presented flow analysis provides quantitative data showing how disrupted blood flow in a single occluded vessel can cause broad and far removed flow alteration in the Circle of Willis. These detailed flow data for cerebral arteries in IS cases may clarify the impact of sudden flow changes and allow further study of flow-related questions that are intractable with current methods, such as the effectiveness with which fibrinolytic agents are delivered to various occlusions and the degree to which flow rate affects the revascularization rate. 9 In this preliminary study, good agreement was found between SAFE analysis and CTP CBF data. However, the connection between arterial flow and tissue perfusion requires further research. We propose that in the future research coupling CTP data with the SAFE analysis can be helpful to differentiate the ability of collateral flow to access ischemic regions in individual patients. In addition, coupling CTP with SAFE and studying patients who have stable CTP may help elucidate the level of arterial flow that is sufficient to maintain a minimal level of brain perfusion and help treatment planning.
Limitations
SAFE analysis integrates the 3D vascular structure of the Circle of Willis generated by clinical CTA images with network flow modeling. However, because of image resolution and the complexity of the vessel network, the major limitation of SAFE is that the flow analysis based on a CTA image may require users to verify the vessel structure. For example, the vessel reconstruction algorithms may include both artery and vein when the contrast intensity are at a similar level, such as at MCA regions, and a correction of vessel morphology may be needed to calculate the blood flow. Further development combining venous flow into SAFE analysis is ongoing to properly simulate the CBF circulation. Another limitation is that currently the SAFE technique does not incorporate leptomeningeal collateral flow. Therefore, in cases when patients have an abundant amount of leptomeningeal collateral circulation, the results of the SAFE technique may underestimate the blood supply. Further development for SAFE analysis is needed for better accuracy and to provide additional information to study leptomeningeal collateral circulation in IS. 10 We aim to couple SAFE with perfusion images and multiphase CTA and to incorporate collateral score into SAFE to improve the analysis.
Conclusion
We present SAFE analysis for collecting detailed timeresolved cerebral arterial flow data in the entire Circle of Willis. We have verified SAFE with CTP data and find good agreement. SAFE analysis based on clinical CTA images can obtain additional CBF information for IS patients, and this additional information may be helpful for IS treatment management. Further study using SAFE with more patient cases, combined with perfusion analysis, will be helpful to test the clinical utilization of SAFE and will be helpful to further study the underlying mechanism of IS and improve IS treatment. 
